COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 633: Articles 6321-6330  | Next

The association between experience of COVID-19-related discrimination and psychological distress among healthcare workers for six national medical research centers in Japan
Manandhar Shrestha, R., Inoue, Y., Yamamoto, S., Fukunaga, A., Sampei, M., Okubo, R., Morisaki, N., Ohmagari, N., Funaki, T., Ishitsuka, K., Yamaguchi, K., Sasaki, Y., Takeda, K., Miyama, T., Kojima, M., Nakagawa, T., Nishimura, K., Ogata, S., Umezawa, J., Tanaka, S., Inoue, M., Konishi, M., Miyo, K., Mizoue, T.
10.1101/2022.08.03.22278304 — Posted: 2022-08-04
A long interval between priming and boosting SARS-CoV-2 mRNA vaccine doses enhances B cell responses with limited impact on T cell immunity
Nicolas, A., Sannier, G., Dube, M., Nayrac, M., Painter, M. M., Goel, R. R., Laporte, M., Medjahed, H. R., Williams, J., Brassard, N., Niessl, J., Gokool, L., Morrisseau, C., Arlotto, P., Tremblay, C., Martel-Laferriere, V., Finzi, A., Greenplate, A., Wherry, E. J., Kaufmann, D. E.
10.1101/2022.08.03.502672 — Posted: 2022-08-04
Neutralization sensitivity of the SARS-CoV-2 Omicron BA.2.75 sublineage
Gruell, H., Vanshylla, K., Tober-Lau, P., Hillus, D., Sander, L. E., Kurth, F., Klein, F.
10.1101/2022.08.04.502609 — Posted: 2022-08-04
Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
Cao, Y. R., Jian, F., Zhang, Z., Yisimayi, A., Hao, X., Bao, L., Yuan, F., Yu, Y., Du, S., Wang, J., Xiao, T., Song, W., Zhang, Y., Liu, P., An, R., Wang, P., Wang, Y., Yang, S., Niu, X., Zhang, Y., Gu, Q., Shao, F., Hu, Y., Yin, W., Zheng, A., Wang, Y., Qin, C., Jin, R., Xiao, J., Xie, X. S.
10.1101/2022.08.03.499114 — Posted: 2022-08-04
Phenotype-driven identification of drug targets for post-COVID-19 anosmia
Catterson, V. M., Sanchez, Y., Musso, G.
10.1101/2022.08.03.502673 — Posted: 2022-08-04
One Health Genomic Surveillance and Response to a University-Based Outbreak of the SARS-CoV-2 Delta AY.25 Lineage, Arizona, 2021
Yaglom, H., Maurer, M., Collins, B., Hojnacki, J. D., Monroy-Nieto, J., Bowers, J. R., Packard, S. D., Erickson, D. E., Barrand, Z. A., Simmons, K. M., Brock, B. N., Lim, E. S., Smith, S., Hepp, C. M., Engelthaler, D. M.
10.1101/2022.08.02.22278212 — Posted: 2022-08-04
Spatio-temporal characteristics of the SARS-CoV-2 Omicron variant spread at fine geographical scales, and comparison to earlier variants
Wood, A. J., Sanchez, A. R., Bessell, P. R., Kao, R. R.
10.1101/2022.08.03.22278013 — Posted: 2022-08-04
Longitudinal analyses after COVID-19 recovery or prolonged infection reveal unique immunological signatures after repeated vaccinations
Hisamatsu, D., Ikeda, A., Ito, L., Matsushita, Y., Hiki, M., Mori, H., Tabe, Y., Naito, T., Akazawa, C.
10.1101/2022.08.03.22278353 — Posted: 2022-08-03
Effects of allocation concealment and blinding in trials addressing treatments for COVID-19: A methods study
Zeraatkar, D., Pitre, T., Diaz-Martinez, J. P., Chu, D., Rochwerg, B., Lamontagne, F., Kum, E., Qasim, A., Bartoszko, J. J., Brignardello-Petersen, R.
10.1101/2022.08.03.22278348 — Posted: 2022-08-03
Real-life evaluation of a rapid antigen test (DPP SARS-CoV-2 Antigen) for COVID-19 diagnosis of primary healthcare patients, in the context of the Omicron-dominant wave in Brazil
Bezerra, M. F., Silva, L. C. A., Pessoa-e-Silva, R., Lino, G., Dezordi, F. Z., Lima, G. B., de Lima, R. E., Campos, T., Docena, C., Oliveira, A., Pitta, M. G. d. R., da Silva, F. d. A. S., Pereira, M., Wallau, G. L., Paiva, M. H. S.
10.1101/2022.08.02.22278277 — Posted: 2022-08-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).